Drug Database
Back to search

Ireland· IE-PA-PA22865/001/001

Pyranistole 200 mg prolonged release capsules

A dipyridamole product containing dipyridamole, registered in Ireland by Renata Pharmaceuticals (Ireland) Limited. The same ATC class is registered in 11 of our 19 countries.

ATC B01AC07

Checked against HPRA (Ireland) on

Informational only — not a medical device.

SOURCE REGISTER · IEHPRA (Ireland)normalisedPyranistole 200 mg prolonged release …ATCB01AC07REGISTER NO.IE-PA-PA22865/001/001PACKS LISTED1CHECKEDSeptember 28, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about dipyridamoleAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Dipyridamole is registered in 11 of 19 countries.

Countries holding a registration under ATC B01AC07 (dipyridamole), each read from that country’s own register.

  • This record: Ireland, from HPRA (Ireland)
  • 6 of them publish a price we can compare per daily dose
Search dipyridamole products by name

Dipyridamole · ATC B01AC07

11 / 19 countries

  • Belgiumprice
  • Canada
  • Denmark
  • Finlandprice
  • Franceprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

HPRA (Ireland)
Active substance
Dipyridamole
Manufacturer
Renata Pharmaceuticals (Ireland) Limited
Country
Ireland (IE)
ATC code
B01AC07
ATC class
Dipyridamole
Defined daily dose
0.4 g, O
Reimbursed
Not published by this register
Source register
HPRA (Ireland)
Last checked
September 28, 2026

Packs & prices · 1

  • ie_pa_number
    PA22865/001/001

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

352 interactions on record for dipyridamole.

Graded by severity as the source publishes them — 47 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check dipyridamole against other medicinesHow interaction checks work

Dipyridamole · interactions on record

352 records

  • 47 severe
  • 93 moderate
  • 5 minor
  • 207 info

Most severe, free to view

  • DalteparinB01AB04severe
  • EnoxaparinB01AB05severe
  • DanaparoidB01AB09severe
  • TinzaparinB01AB10severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Dipyridamole in 11 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All dipyridamole products

Authorised across Europe · EMA

The same active substance is authorised in 17 EEA countries. Names it is sold under:

  • Austria · Persantin
  • Bulgaria · Антистенокардин, Биокардин
  • Cyprus · Perazodin, Persantin
  • Denmark · Dipyridamol Alternova, Dipyridamol Strides
  • Spain · Persantin
  • Finland · Persantin
  • France · Persantine
  • United Kingdom (Northern Ireland) · Attia, Dipyridamole Dr. Reddy’s
  • Greece · Persantin
  • Croatia · Persantin
  • Iceland · Persantin
  • Italy · Corosan, Persantin
  • Malta · Perazodin
  • Netherlands · Dipyridamol Glenmark, Dipyridamol Sandoz
  • Norway · Aponova, Dipyridamol Glenmark
  • Portugal · Dipiridamol Labesfal, Persantin
  • Sweden · Dipyridamol Alternova, Pyranistole

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/edfc0077-e4c7-46dc-a77b-dec313dcabdf
GET /v1/drugs/edfc0077-e4c7-46dc-a77b-dec313dcabdf?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Prolonged-release capsule, hard",
  "routes": [
    "Oral use"
  ],
  "source": "hpra",
  "atc_all": [
    "B01AC",
    "B01AC07"
  ],
  "strength": null,
  "pa_number": "PA22865/001/001",
  "substances": [
    "Dipyridamole"
  ],
  "legal_basis": "Generic application (Article 10(1) of Directive No 2001/83/EC)",
  "market_info": "Marketed",
  "authorised_at": "06/07/2018",
  "dispensing_status": "Product subject to prescription which may be renewed (B)",
  "registration_status": "AU",
  "supply_legal_status": "Supply through pharmacies only",
  "interchangeable_code": null
}
API referenceMCP serverPlans

See everything about dipyridamole.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console